C
Systemic sclerosis
Comorbid ConditionsDisease / conditionrisknon modifiable
8
evidence score
Also known as: systemic sclerosis (SSc)
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 3meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Review on anti-lipoprotein lipase antibodies. — Clinica chimica acta; international journal of clinical chemistry 2010 · PMID 20673827
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT01315899 | Phase IIa Study of the Efficacy of ORM-12471 for Prevention of Cold-induced Vasospasm: a Randomised, Double-blind, Placebo-controlled, Single Centre Crossover Study in Patients With Raynaud's Phenomenon Secondary to Systemic Sclerosis | TERMINATED | INTERVENTIONAL | ORM-12471 30mg, ORM-12471, placebo |
| NCT00377949 | The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension | COMPLETED | OBSERVATIONAL |
Genetic associations (0)
None linked.